Cargando…
Relative selenium insufficiency is a risk factor for developing severe Graves’ orbitopathy: a case–control study
BACKGROUND/AIMS: Selenium (Se), an antioxidant agent, is effective in preventing mild Graves’ orbitopathy (GO) deterioration. However, the significant risk of low serum Se concentration for GO progression has not been identified. Here, we aimed to investigate the risk of relative Se insufficiency an...
Autores principales: | Lumyongsatien, Mingkwan, Bhaktikamala, Unnkade, Thongtong, Pennung, Sintuwong, Sunisa, Nimitwongsakul, Ornvenus, Kanokkantapong, Jugchawin, Pongpirul, Krit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8112433/ https://www.ncbi.nlm.nih.gov/pubmed/34041363 http://dx.doi.org/10.1136/bmjophth-2021-000713 |
Ejemplares similares
-
Planning health care for patients with Graves’ orbitopathy
por: Sasim, Inna V., et al.
Publicado: (2008) -
18 F-FDG-PET/MRI in patients with Graves’ orbitopathy.
por: Weber, Manuel, et al.
Publicado: (2021) -
Balancing orbital volume reduction and redistribution for a tailored surgical treatment in Graves’ ophthalmopathy
por: Costan, Victor Vlad, et al.
Publicado: (2020) -
Monocanalicular versus bicanalicular intubation in the treatment of congenital nasolacrimal duct obstruction
por: Komínek, Pavel, et al.
Publicado: (2011) -
Success rate and complications of endonasal dacryocystorhinostomy with unciformectomy
por: Yang, Jae Wook, et al.
Publicado: (2012)